Get the app!
Back to Trades
Grant4

VERTEX PHARMACEUTICALS INC / MA

VRTX

Total Value
$924.9K

Company Information

Ticker Symbol
VRTX
CIK
0000875320

Insider Information

Role
EVP and CMO
Officer
Location
BOSTON, MA

Filing Details

Filing Date
Feb 19, 2026
Transaction Date
Feb 17, 2026
Accession Number
0000875320-26-000086
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 17, 2026Common Stock5,375Grant/Award
Feb 17, 2026Common Stock1,912$483.75Tax Withholding$924.9K

Footnotes

  1. (F1)Restricted stock unit award that vests in installments beginning on February 20, 2027.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.